Evidence map›Paper›PMID 35251954›Full record

ArticleFrontiers in oncology2022

Analysis of

Wei Chen, Wei Xia, Song Xue, Hang Huang, Qi Lin, Yi Liu, Tongtong Liu, Yiqun Zhang, Panwang Zhang, Jianfei Wang and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Droplet Digital PCR Improves Detection ofInternational journal of molecular sciences · 2025
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Wei ChenDepartment of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou City, China.
Wei XiaDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Song XueDepartment of Urology, General Hospital of Eastern Theater Command, Nanjing, China.
Hang HuangDepartment of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou City, China.
Qi LinDepartment of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou City, China.
Yi LiuDepartment of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou City, China.
Tongtong LiuResearch Institute, GloriousMed Clinical Laboratory Co., Ltd., Shanghai, China.
Yiqun ZhangResearch Institute, GloriousMed Clinical Laboratory Co., Ltd., Shanghai, China.
Panwang ZhangResearch Institute, GloriousMed Clinical Laboratory Co., Ltd., Shanghai, China.
Jianfei WangResearch Institute, GloriousMed Clinical Laboratory Co., Ltd., Shanghai, China.
Yining YangResearch Institute, GloriousMed Clinical Laboratory Co., Ltd., Shanghai, China.
Baijun DongDepartment of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Zhixian YuDepartment of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou City, China.
Wenzhou Medical University · CNFirst Affiliated Hospital of Wenzhou Medical University · CNJiangsu Province Hospital · CNNanjing General Hospital of Nanjing Military Command · CNRenji Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies have indicated that prostate cancer (PCa) with

Indexed as

BRCA1 and BRCA2 germline mutationsBRCA variantspathogenic rateprostate cancer in Chinasomatic mutation

Identifiers

PMID35251954
PMCPMC8892236
OpenAlexW4226115119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.